| Clinical data | |
|---|---|
| Trade names | Etaproctene (with lidocaine and tetryzoline) |
| Other names | Prednisolone 21-diethylaminoacetate; 11β,17α,21-Trihydroxypregna-1,4-diene-3,20-dione 21-N,N-diethylglycine ester |
| Drug class | Corticosteroid; Glucocorticoid |
| Identifiers | |
| |
| CAS Number |
|
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.024.605 |
| Chemical and physical data | |
| Formula | C27H39NO6 |
| Molar mass | 473.610 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Prednisolamate, also known as prednisolone 21-diethylaminoacetate, is a synthetic corticosteroid. It is or was a component of Etaproctene, which contains lidocaine, prednisolamate hydrochloride, and tetryzoline.
| Glucocorticoids | |
|---|---|
| Antiglucocorticoids |
|
| Synthesis modifiers | |
| |
| Mineralocorticoids | |
|---|---|
| Antimineralocorticoids | |
| Synthesis modifiers | |
| |
| MRTooltip Mineralocorticoid receptor |
| ||||
|---|---|---|---|---|---|